Raymond James Financial Services Advisors, Inc. Adamis Pharmaceuticals Corp Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 17, 2020
SELL
$0.33 - $0.66 $4,325 - $8,650
-13,107 Closed
0 $0
Q4 2019

Feb 12, 2020
SELL
$0.51 - $1.26 $2,805 - $6,930
-5,500 Reduced 29.56%
13,107 $9,000
Q2 2019

Aug 06, 2019
SELL
$1.26 - $2.23 $2,154 - $3,813
-1,710 Reduced 8.42%
18,607 $24,000
Q1 2019

May 06, 2019
BUY
$2.02 - $3.22 $12,120 - $19,320
6,000 Added 41.91%
20,317 $43,000
Q4 2018

Feb 11, 2019
SELL
$2.1 - $3.21 $12,232 - $18,698
-5,825 Reduced 28.92%
14,317 $32,000
Q3 2018

Nov 14, 2018
BUY
$2.25 - $4.8 $45,319 - $96,681
20,142 New
20,142 $70,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email